|
1. Available at: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001940/ Accessed August 21, 2011.
2. Schutze M, Boeing H, Pischon T, et al. Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study. BMJ. 2011;342:d1584.
3. Druesne-Pecollo N, Tehard B, Mallet Y, et al. Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer. Lancet Oncol. 2009 Feb;10(2):173-80.
4. Juliano C, Cossu M, Rota MT, Satta D, Poggi P, Giunchedi P. Buccal tablets containing cysteine and chlorhexidine for the reduction of acetaldehyde levels in the oral cavity. Drug Dev Ind Pharm. 2011 Mar 31.
5. Brooks PJ, Theruvathu JA. DNA adducts from acetaldehyde: implications for alcohol-related carcinogenesis. Alcohol. 2005 Apr;35(3):187-93.
6. Poschl G, Seitz HK. Alcohol and cancer. Alcohol Alcohol. 2004 May-Jun;39(3):155-65.
7. Seitz HK, Homann N. The role of acetaldehyde in alcohol-associated cancer of the gastrointestinal tract. Novartis Found Symp. 2007;285:110-9; discussion 119-4, 198-9.
8. Seitz HK, Stickel F. Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress. Biol Chem. 2006 Apr;387(4):349-60.
9. Penning R, van Nuland M, Fliervoet LA, Olivier B, Verster JC. The pathology of alcohol hangover. Curr Drug Abuse Rev. 2010 Jun;3(2):68-75.
10. Yu HS, Oyama T, Isse T, et al. Formation of acetaldehyde-derived DNA adducts due to alcohol exposure. Chem Biol Interact. 2010 Dec 5;188(3):367-75.
11. Giovannucci E, Stampfer MJ, Colditz GA, et al. Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst. 1993 Jun 2;85(11):875-84.
12. Vasdev S, Wadhawan S, Ford CA, Parai S, Longerich L, Gadag V. Dietary vitamin B6 supplementation prevents ethanol-induced hypertension in rats. Nutr Metab Cardiovasc Dis. 1999 Apr;9(2):55-63.
13. Sellers TA, Kushi LH, Cerhan JR, et al. Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women. Epidemiology. 2001 Jul;12(4):420-8.
14. Winstanley MH, Pratt IS, Chapman K, et al. Alcohol and cancer: a position statement from Cancer Council Australia. Med J Aust. 2011 May 2;194(9):479-82.
15. Brien SE, Ronksley PE, Turner BJ, Mukamal KJ, Ghali WA. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies. BMJ. 2011 Feb 22;342:d636.
16. Hendler RA, Ramchandani VA, Gilman J, Hommer DW. Stimulant and sedative effects of alcohol. Curr Top Behav Neurosci. 2011 May 11.
17. Negri E, Franceschi S, Bosetti C, et al. Selected micronutrients and oral and pharyngeal cancer. Int J Cancer. 2000 Apr 1;86(1):122-7.
18. Bulger EM, Helton WS. Nutrient antioxidants in gastrointestinal diseases. Gastroenterol Clin North Am. 1998 Jun;27(2):403-19
19. Alabaster O, Tang Z, Shivapurkar N. Dietary fiber and the chemopreventive modelation of colon carcinogenesis. Mutat Res. 1996 Feb 19;350(1):185-97.
20. Jedrychowski W, Steindorf K, Popiela T, et al. Risk of colorectal cancer from alcohol consumption at lower vitamin intakes. A hospital-based case-control study in Poland. Rev Environ Health. 2001 Jul-Sep;16(3):213-22.
21. Jedrychowski W, Steindorf K, Popiela T, et al. Alcohol consumption and the risk of colorectal cancer at low levels of micronutrient intake. Med Sci Monit. 2002 May;8(5):CR357-63.
22. Ha HL, Shin HJ, Feitelson MA, Yu DY. Oxidative stress and antioxidants in hepatic pathogenesis. World J Gastroenterol. 2010 Dec 28;16(48):6035-43.
23. Yang CS, Lu G, Ju J, Li GX. Inhibition of inflammation and carcinogenesis in the lung and colon by tocopherols. Ann N Y Acad Sci. 2010 Aug;1203:29-34.
24. Park Y, Spiegelman D, Hunter DJ, et al. Intakes of vitamins A, C, and E and use of multiple vitamin supplements and risk of colon cancer: a pooled analysis of prospective cohort studies. Cancer Causes Control. 2010 Nov;21(11):1745-57.
25. Sheweita SA, Sheikh BY. Can dietary antioxidants reduce the incidence of brain tumors? Curr Drug Metab. 2011 Mar 25.
26. Brozmanova J, Manikova D, Vlckova V, Chovanec M. Selenium: a double-edged sword for defense and offence in cancer. Arch Toxicol. 2010 Dec;84(12):919-38.
27. Kautiainen A, Tornqvist M, Olsson U. Effects of selenium deficiency on the formation and detoxification of endogenous electrophiles in rats. J Nutr Biochem. 2000 Sep;11(9):425-30.
28. Feng Y, Finley JW, Davis CD, Becker WK, Fretland AJ, Hein DW. Dietary selenium reduces the formation of aberrant crypts in rats administered 3,2'-dimethyl-4-aminobiphenyl. Toxicol Appl Pharmacol. 1999 May 15;157(1):36-42.
29. Ferguson LR, Karunasinghe N, Philpott M. Epigenetic events and protection from colon cancer in New Zealand. Environ Mol Mutagen. 2004;44(1):36-43.
30. Dey Sarkar P, Ramprasad N, Dey Sarkar I, Shivaprakash TM. Study of oxidative stress and trace element levels in patients with alcoholic and non-alcoholic coronary artery disease. Indian J Physiol Pharmacol. 2007 Apr-Jun;51(2):141-6.
31. Sakoda LC, Graubard BI, Evans AA, et al. Toenail selenium and risk of hepatocellular carcinoma mortality in Haimen City, China. Int J Cancer. 2005 Jul 1;115(4):618-24.
32. McKillop IH, Schrum LW. Alcohol and liver cancer. Alcohol. 2005 Apr;35(3):195-203.
33. Pascale R, Daino L, Garcea R, et al. Inhibition by ethanol of rat liver plasma membrane (Na+,K+)ATPase: protective effect of S-adenosyl-L-methionine, L-methionine, and N-acetylcysteine. Toxicol Appl Pharmacol. 1989 Feb;97(2):216-29.
34. Novitskiy G, Traore K, Wang L, Trush MA, Mezey E. Effects of ethanol and acetaldehyde on reactive oxygen species production in rat hepatic stellate cells. Alcohol Clin Exp Res. 2006 Aug;30(8):1429-35.
35. Klein-Schwartz W, Doyon S. Intravenous acetylcysteine for the treatment of acetaminophen overdose. Expert Opin Pharmacother. 2011 Jan;12(1):119-30.
36. Sprince H, Parker CM, Smith GG, Gonzales LJ. Protective action of ascorbic acid and sulfur compounds against acetaldehyde toxicity: implications in alcoholism and smoking. Agents Actions. 1975 May;5(2):164-73.
37. Vasdev S, Mian T, Longerich L, Prabhakaran V, Parai S. N-acetyl cysteine attenuates ethanol induced hypertension in rats. Artery. 1995;21(6):312-6.
38. Balakumar P, Rohilla A, Krishan P, Solairaj P, Thangathirupathi A. The multifaceted therapeutic potential of benfotiamine. Pharmacol Res. 2010 Jun;61(6):482-8.
39. Schmid U, Stopper H, Heidland A, Schupp N. Benfotiamine exhibits direct antioxidative capacity and prevents induction of DNA damage in vitro. Diabetes Metab Res Rev. 2008 Jul-Aug;24(5):371-7.
40. Ansari NA, Rasheed Z. Non-enzymatic glycation of proteins: from diabetes to cancer. Biomed Khim. 2010 Mar-Apr;56(2):168-78.
41. Ayazpoor U. Chronic alcohol abuse. Benfotiamine in alcohol damage is a must. MMW Fortschr Med. 2001 Apr 19;143(16):53.
42. Schupp N, Dette EM, Schmid U, et al. Benfotiamine reduces genomic damage in peripheral lymphocytes of hemodialysis patients. Naunyn Schmiedebergs Arch Pharmacol. 2008 Sep;378(3):283-91.
43. Folate, alcohol, methionine, and colon cancer risk: is there a unifying theme? Nutr Rev. 1994 Jan;52(1):18-20.
44. Dinsmore WW, McMaster D, Callender ME, Buchanan KD, Love AH. Trace elements and alcohol. Sci Total Environ. 1985 Mar 15;42(1-2):109-19.
45. Purohit V, Khalsa J, Serrano J. Mechanisms of alcohol-associated cancers: introduction and summary of the symposium. Alcohol. 2005 Apr;35(3):155-60.
46. Potter JD. Methyl supply, methyl metabolizing enzymes and colorectal neoplasia. J Nutr. 2002 Aug;132(8 Suppl):2410S-12S.
47. Hermann S, Rohrmann S, Linseisen J. Lifestyle factors, obesity and the risk of colorectal adenomas in EPIC-Heidelberg. Cancer Causes Control. 2009 Oct;20(8):1397-408.
48. Lu SC, Mato JM. Role of methionine adenosyltransferase and S-adenosylmethionine in alcohol-associated liver cancer. Alcohol. 2005 Apr;35(3):227-34.
49. Prasad AS, Beck FW, Snell DC, Kucuk O. Zinc in cancer prevention. Nutr Cancer. 2009;61(6):879-87.
50. Holguin F, Moss I, Brown LA, Guidot DM. Chronic ethanol ingestion impairs alveolar type II cell glutathione homeostasis and function and predisposes to endotoxin-mediated acute edematous lung injury in rats. J Clin Invest. 1998 Feb 15;101(4):761-8.
51. Powell CL, Bradford BU, Craig CP, et al. Mechanism for prevention of alcohol-induced liver injury by dietary methyl donors. Toxicol Sci. 2010 May;115(1):131-9.
52. Egner PA, Munoz A, Kensler TW. Chemoprevention with chlorophyllin in individuals exposed to dietary aflatoxin. Mutat Res. 2003 Feb-Mar;523-524:209-16.
53. Egner PA, Wang JB, Zhu YR, et al. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14601-6.
54. Kensler TW, Egner PA, Wang JB, et al. Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas. Gastroenterology. 2004 Nov;127(5 Suppl 1):S310-8.
55. Ferguson LR, Philpott M, Karunasinghe N. Dietary cancer and prevention using antimutagens. Toxicology. 2004 May 20;198(1-3):147-59.
56. Fahey JW, Stephenson KK, Dinkova-Kostova AT, Egner PA, Kensler TW, Talalay P. Chlorophyll, chlorophyllin and related tetrapyrroles are significant inducers of mammalian phase 2 cytoprotective genes. Carcinogenesis. 2005 Jul;26(7):1247-55.
57. Yun CH, Son CG, Chung DK, Han SH. Chlorophyllin attenuates IFN-gamma expression in lipopolysaccharide-stimulated murine splenic mononuclear cells via suppressing IL-12 production. Int Immunopharmacol. 2005 Dec;5(13-14):1926-35.
58. Simonetti P, Ciappellano S, Gardana C, Bramati L, Pietta P. Procyanidins from Vitis vinifera seeds: in vivo effects on oxidative stress. J Agric Food Chem. 2002 Oct 9;50(21):6217-21.
59. Fan P, Lou H. Effects of polyphenols from grape seeds on oxidative damage to cellular DNA. Mol Cell Biochem. 2004 Dec;267(1-2):67-74.
60. Llopiz N, Puiggros F, Cespedes E, et al. Antigenotoxic effect of grape seed procyanidin extract in Fao cells submitted to oxidative stress. J Agric Food Chem. 2004 Mar 10;52(5):1083-7.
61. Lu Y, Zhao WZ, Chang Z, Chen WX, Li L. Procyanidins from grape seeds protect against phorbol ester-induced oxidative cellular and genotoxic damage. Acta Pharmacol Sin. 2004 Aug;25(8):1083-9.
62. Busserolles J, Gueux E, Balasinska B, et al. In vivo antioxidant activity of procyanidin-rich extracts from grape seed and pine (Pinus maritima) bark in rats. Int J Vitam Nutr Res. 2006 Jan;76(1):22-7.
63. El-Ashmawy IM, Saleh A, Salama OM. Effects of marjoram volatile oil and grape seed extract on ethanol toxicity in male rats. Basic Clin Pharmacol Toxicol. 2007 Nov;101(5):320-7.
64. Guo L, Wang LH, Sun B, et al. Direct in vivo evidence of protective effects of grape seed procyanidin fractions and other antioxidants against ethanol-induced oxidative DNA damage in mouse brain cells. J Agric Food Chem. 2007 Jul 11;55(14):5881-91.
65. Sano A, Yamakoshi J, Tokutake S, Tobe K, Kubota Y, Kikuchi M. Procyanidin B1 is detected in human serum after intake of proanthocyanidin-rich grape seed extract. Biosci Biotechnol Biochem. 2003 May;67(5):1140-3.
66. Ward NC, Croft KD, Puddey IB, Hodgson JM. Supplementation with grape seed polyphenols results in increased urinary excretion of 3-hydroxyphenylpropionic Acid, an important metabolite of proanthocyanidins in humans. J Agric Food Chem. 2004 Aug 25;52(17):5545-9.
67. Feher J, Lengyel G. Silymarin in the treatment of chronic liver diseases: past and future. Orv Hetil. 2008 Dec 21;149(51):2413-8.
68. Brandon-Warner E, Sugg JA, Schrum LW, McKillop IH. Silibinin inhibits ethanol metabolism and ethanol-dependent cell proliferation in an in vitro model of hepatocellular carcinoma. Cancer Lett. 2010 May 1;291(1):120-9.
69. Feher J, Lengyel G. Silymarin in the prevention and treatment of liver diseases and primary liver cancer. Curr Pharm Biotechnol. 2011 Apr 5.
70. Ralhan R, Pandey MK, Aggarwal BB. Nuclear factor-kappa B links carcinogenic and chemopreventive agents. Front Biosci (Schol Ed). 2009;1:45-60.
71. Rajkumar V, Guha G, Kumar RA. Antioxidant and anti-neoplastic activities of Picrorhiza kurroa extracts. Food Chem Toxicol. 2011 Feb;49(2):363-9.
72. Rastogi R, Saksena S, Garg NK, Kapoor NK, Agarwal DP, Dhawan BN. Picroliv protects against alcohol-induced chronic hepatotoxicity in rats. Planta Med. 1996 Jun;62(3):283-5.
73. Saraswat B, Visen PK, Patnaik GK, Dhawan BN. Ex vivo and in vivo investigations of picroliv from Picrorhiza kurroa in an alcohol intoxication model in rats. J Ethnopharmacol. 1999 Sep;66(3):263-9.
74. Rajeshkumar NV, Kuttan R. Inhibition of N-nitrosodiethylamine-induced hepatocarcinogenesis by Picroliv. J Exp Clin Cancer Res. 2000 Dec;19(4):459-65.
75. Rajeshkumar NV, Kuttan R. Protective effect of Picroliv, the active constituent of Picrorhiza kurroa, against chemical carcinogenesis in mice. Teratog Carcinog Mutagen. 2001;21(4):303-13.
76. Anand P, Kunnumakkara AB, Harikumar KB, Ahn KS, Badmaev V, Aggarwal BB. Modification of cysteine residue in p65 subunit of nuclear factor-kappaB (NF-kappaB) by picroliv suppresses NF-kappaB-regulated gene products and potentiates apoptosis. Cancer Res. 2008 Nov 1;68(21):8861-70.
77. McIntosh GH, Jorgensen L, Royle P. The potential of an insoluble dietary fiber-rich source from barley to protect from DMH-induced intestinal tumors in rats. Nutr Cancer. 1993;19(2):213-21.
78. McIntosh GH, Le Leu RK, Royle PJ, Young GP. A comparative study of the influence of differing barley brans on DMH-induced intestinal tumours in male Sprague-Dawley rats. J Gastroenterol Hepatol. 1996 Feb;11(2):113-9.
79. Jeong HJ, Jeong JB, Hsieh CC, Hernandez-Ledesma B, de Lumen BO. Lunasin is prevalent in barley and is bioavailable and bioactive in in vivo and in vitro studies. Nutr Cancer. 2010;62(8):1113-9.
80. Jeong HJ, Lam Y, de Lumen BO. Barley lunasin suppresses ras-induced colony formation and inhibits core histone acetylation in mammalian cells. J Agric Food Chem. 2002 Oct 9;50(21):5903-8.
81. Kanauchi O, Mitsuyama K, Andoh A, Iwanaga T. Modulation of intestinal environment by prebiotic germinated barley foodstuff prevents chemo-induced colonic carcinogenesis in rats. Oncol Rep. 2008 Oct;20(4):793-801.
82. Manzo-Avalos S, Saavedra-Molina A. Cellular and mitochondrial effects of alcohol consumption. Int J Environ Res Public Health. 2010 Dec;7(12):4281-304.
83. Yan Y, Yang J, Chen G, et al. Protection of resveratrol and its analogues against ethanol-induced oxidative DNA damage in human peripheral lymphocytes. Mutat Res. 2011 Apr 3;721(2):171-7.
84. Agarwal B, Baur JA. Resveratrol and life extension. Ann N Y Acad Sci. 2011 Jan;1215:138-43.
85. Shen Z, Ajmo JM, Rogers CQ, et al. Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-alpha production in cultured macrophage cell lines. Am J Physiol Gastrointest Liver Physiol. 2009 May;296(5):G1047-53.
86. Newcomb PA, Carbone PP. The health consequences of smoking. Cancer. Med Clin North Am. 1992 Mar;76(2):305-31.
87. Capewell S, Hayes DK, Ford ES, et al. Life-years gained among US adults from modern treatments and changes in the prevalence of 6 coronary heart disease risk factors between 1980 and 2000. Am J Epidemiol. 2009 Jul 15;170(2):229-36.
88. Cowling DW, Yang J. Smoking-attributable cancer mortality in California, 1979-2005. Tob Control. 2010 Apr;19 Suppl 1:i62-7. |